Skip to main content

Peer Review reports

From: The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma

Original Submission
28 Feb 2022 Submitted Original manuscript
1 Apr 2022 Reviewed Reviewer Report
2 Apr 2022 Reviewed Reviewer Report
26 Apr 2022 Author responded Author comments - Haruki Uojima
Resubmission - Version 2
26 Apr 2022 Submitted Manuscript version 2
29 Apr 2022 Author responded Author comments - Haruki Uojima
Resubmission - Version 3
29 Apr 2022 Submitted Manuscript version 3
30 Apr 2022 Author responded Author comments - Haruki Uojima
Resubmission - Version 4
30 Apr 2022 Submitted Manuscript version 4
9 May 2022 Author responded Author comments - Haruki Uojima
Resubmission - Version 5
9 May 2022 Submitted Manuscript version 5
25 May 2022 Reviewed Reviewer Report
26 May 2022 Reviewed Reviewer Report
12 Jul 2022 Author responded Author comments - Haruki Uojima
Resubmission - Version 6
12 Jul 2022 Submitted Manuscript version 6
13 Jul 2022 Author responded Author comments - Haruki Uojima
Resubmission - Version 7
13 Jul 2022 Submitted Manuscript version 7
4 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
5 Aug 2022 Editorially accepted
23 Aug 2022 Article published 10.1186/s12885-022-10002-x

You can find further information about peer review here.

Back to article page